Lab Information
Vivian Loo (MD/MSc)
InvestigatorClinical Research Unit
Department of Medicine (McGill)
Research Profile
Keywords
Clostridium difficile • healthcare-associated infections • infection controlResearch Interests
My research focuses on healthcare-associated infections and I have a particular interest in Clostridium difficile infections (CDI) . My research examines the epidemiology of CDI, looking at risk factors for infection and colonization as well as different strategies for prevention of transmssion. I am also involved in the evaluation of rapid diagnostic tests for CDI.Team Members
| Name | Position |
|---|
Latest Publications
- Li, J., Dendukuri, N., Longtin, Y., Banz, A., Frenette, C., Gervais, P., Miller, M. A., Bourgault, A.--. M., Dawang, N. L. & Loo, V. G. (2025). Determination of the performance of a novel diagnostic test for Clostridioides difficile toxins A and B using latent class analysis. Journal of clinical microbiology, p. e0180724.
- Couture, S., Frenette, C., Schiller, I., Alfaro, R., Dendukuri, N., Thirion, D., Longtin, Y. & Loo, V. G. (2024). The changing epidemiology of Clostridioides difficile infection and the NAP1/027 strain in two Québec hospitals: a 17-year time-series study. Antimicrobial stewardship & healthcare epidemiology : ASHE, vol. 4, p. e99.
- Huletsky, A., Loo, V. G., Longtin, Y., Longtin, J., Trottier, S., Tremblay, C. L., Gilca, R., Lavallée, C., Brochu, É., Bérubé, È., Bastien, M., Bernier, M., Gagnon, M., Frenette, J., Bestman-Smith, J., Deschênes, L. & Bergeron, M. G. (2024). Comparison of rectal swabs and fecal samples for the detection of Clostridioides difficile infections with a new in-house PCR assay. Microbiology spectrum, p. e0022524.
- Kociolek, L. K., Gerding, D. N., Carrico, R., Carling, P., Donskey, C. J., Dumyati, G., Kuhar, D. T., Loo, V. G., Maragakis, L. L., Pogorzelska-Maziarz, M., Sandora, T. J., Weber, D. J., Yokoe, D. & Dubberke, E. R. (2023). Strategies to prevent Clostridioides difficile infections in acute-care hospitals: 2022 Update. Infection control and hospital epidemiology, vol. 44, p. 527-549.
- Li, J., Frenette, C. & Loo, V. G. (2022). Diagnostic yield of serial SARS-CoV-2 testing in hospitalized patients. Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada, vol. 7, p. 181-185.
- Loo, V. G., Roussel, L., Bernier, S., Perez, A. & Vinh, D. C. (2022). Late-Onset Combined Immunodeficiency with Refractory CMV Disease due to ICOSL Deficiency. Journal of clinical immunology, vol. 42, p. 206-209.
- Schweitzer, L., Gervais, P., Paquet-Bolduc, B., Loo, V. G. & Longtin, Y. (2021). Detection of Free Toxin B in the Stool of Asymptomatic Clostridioides difficile Carriers by the Cell Cytotoxicity Neutralization Assay. Open forum infectious diseases, vol. 8, p. ofab209.
- Gilbert, L., Miller, K., Medeiros, D., Tsatoumas, M., Ciarallo, A., Isabwe, G., Malek, J., Loo, V. G. & Kumar, P. N. (2020). A disease disregards anatomical planes: actinomycosis and an intrauterine device. Lancet (London, England), vol. 396, p. 1766.
- Golizeh, M., Winter, K., Roussel, L., Landekic, M., Langelier, M., Loo, V. G., Ndao, M. & Vinh, D. C. (2021). Fecal host biomarkers predicting severity of Clostridioides difficile infection. JCI insight, vol. 6.
- Mashock, M. J., Faron, M. L., Carroll, K. C., Dang, C., Lewis, S., Salimnia, H., Lephart, P., Loo, V. G., Schmitt, B. H., Young, S., Buchan, B. W. & Ledeboer, N. A. (2020). A Multicenter Study of the Revogene C. difficile System for Detection of the Toxin B Gene from Unformed Stool Specimens. Journal of clinical microbiology, vol. 58.
See also
